[2025 ESC Guidelines for the management of cardiovascular disease and pregnancy] [0.03%]
2025年欧洲心脏协会心血管疾病与妊娠管理指南
Julie De Backer,Kristina H Haugaa,Nina Eide Hasselberg et al.
Julie De Backer et al.
[Reply to "A critical appraisal of evidence from the VICTOR trial and the VICTOR/VICTORIA pooled analysis: a statistical perspective"] [0.03%]
[VICTOR试验和VICTOR/VICTORIA合并分析证据的统计学评论的回复]
Giuseppe Di Tano,Luca Antonio Felice Di Odoardo,Michele Senni
Giuseppe Di Tano
[A critical appraisal of evidence from the VICTOR trial and the VICTOR/VICTORIA pooled analysis: a statistical perspective] [0.03%]
从统计学角度对VICTOR试验和VICTOR/VICTORIA合并分析证据的批判性评价
Francesco Fugetto
Francesco Fugetto
[Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC)] [0.03%]
轻链型淀粉样变性：意大利心脏淀粉样变性工作组（RIAC）的多学科管理及创新治疗策略专家共识文件(SIC/ANMCO)
Alberto Aimo,Giuseppe Vergaro,Vincenzo Castiglione et al.
Alberto Aimo et al.
Light chain (AL) amyloidosis is a rare systemic disease caused by monoclonal immunoglobulin light chains with abnormal folding that aggregate into fibrils, which deposit in extracellular tissues. This process leads to cytotoxicity and organ...
Practice Guideline
Giornale italiano di cardiologia (2006). 2026 Feb;27(2):141-153. DOI:10.1714/4636.46471 2026
[Clear Pathway: the role of bempedoic acid in lipid-lowering strategies. The opinion of cardiologists from Piedmont and Aosta Valley, Italy] [0.03%]
清晰之路：意大利皮埃蒙特和奥斯塔谷地区心脏病专家谈贝美普利酸在降脂策略中的作用及看法
Federico Nardi,Giuseppe Patti,Giorgio Quadri et al.
Federico Nardi et al.
Background: Although international guidelines recommend increasingly lower thresholds for low-density lipoprotein cholesterol (LDL-C), everyday clinical experience shows that many patients fail to reach these targets, exp...
[Modulation of the cholesteryl ester transfer protein: new perspectives for the management of cardiovascular risk] [0.03%]
胆固醇酯转移蛋白的调节：降低心血管风险的新视角
Pietro Scicchitano,Claudio Bilato
Pietro Scicchitano
Despite the widespread use of lipid-lowering therapies, a significant proportion of patients with atherosclerotic cardiovascular disease fail to achieve the recommended LDL-cholesterol targets, thus remaining at high residual risk. Inhibiti...
[Angina in non-obstructive coronary artery disease: some examples from daily practice] [0.03%]
非冠状动脉狭窄性心绞痛的诊断和治疗（经验分享）
Alberto Sarti,Serena Caglioni,Antonio Maria Leone et al.
Alberto Sarti et al.
Angina in non-obstructive coronary artery disease (ANOCA) is a common clinical condition affecting 20-50% of patients undergoing coronary angiography for suspected angina. Despite recent 2024 European guidelines on chronic coronary syndrome...
[Amyloidosis in the elderly: a clinical enigma between frailty and diagnosis] [0.03%]
老年患者的淀粉样变性：诊断与衰弱之间的临床难题
Donatella Del Sindaco,Giovanni Pulignano,Nadia Ingianni et al.
Donatella Del Sindaco et al.
Cardiac amyloidosis is considered a rare disease but is increasingly frequent in elderly patients. In these patients, heterogeneous and peculiar clinical manifestations require specific approaches and dedicated diagnostic-therapeutic pathwa...
[Artificial intelligence in the diagnosis and management of aortic disease: current applications and future directions] [0.03%]
[人工智能在主动脉疾病诊断和管理中的应用及未来发展方向]
Francesco Buia,Luca Bergamaschi,Paola Franceschi et al.
Francesco Buia et al.
Artificial intelligence (AI) is rapidly transforming the field of aortic imaging, enhancing diagnostic accuracy, risk stratification, and treatment planning. This review provides a comprehensive overview of AI applications in measuring aort...
Elisa Soranzo,Laura Munaretto,Gianfranco Sinagra
Elisa Soranzo